D R Chisholm
Overview
Explore the profile of D R Chisholm including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
18
Citations
169
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
2.
Leitner F, PURSIANO T, BUCK R, Tsai Y, Chisholm D, MISIEK M, et al.
Antimicrob Agents Chemother
. 1987 Feb;
31(2):238-43.
PMID: 3105449
BMY 28100, a new oral cephalosporin with a (Z)-propenyl side chain at the 3 position and a p-hydroxyphenylglycyl substituent at the 7 position, was evaluated in comparison with cefaclor and...
3.
Chisholm D, DeRegis R, Behr D
Antimicrob Agents Chemother
. 1986 Jul;
30(1):105-9.
PMID: 3752972
The therapeutic efficacies of cefadroxil and cephalexin were compared in a Streptococcus pyogenes-induced lung infection in rats. Although MICs, rates of in vitro killing in rat serum, and antibiotic serum...
4.
MISIEK M, BUCK R, PURSIANO T, Chisholm D, Tsai Y, PRICE K, et al.
Antimicrob Agents Chemother
. 1985 Dec;
28(6):761-5.
PMID: 3878689
We explored the antibacterial activity of phosphanilic acid (P), an analog of sulfanilic acid, alone and in combination with trimethoprim (T; TP, 1:5) with sulfamethoxazole (S) and co-trimoxazole, the combination...
5.
Kessler R, Bies M, BUCK R, Chisholm D, PURSIANO T, Tsai Y, et al.
Antimicrob Agents Chemother
. 1985 Feb;
27(2):207-16.
PMID: 3885849
BMY 28142, a new broad-spectrum semisynthetic cephalosporin, was evaluated in vitro and in vivo in comparison with ceftazidime, cefotaxime, moxalactam, and cefoperazone. The activity of BMY 28142 compared favorably with...
6.
Leitner F, MISIEK M, PURSIANO T, BUCK R, Chisholm D, DeRegis R, et al.
Antimicrob Agents Chemother
. 1976 Sep;
10(3):426-35.
PMID: 984784
Biological and physicochemical properties of BL-S786 were compared with those of cephalothin, cephaloridine, and cefazolin. With few exceptions, BL-S786 was more active than the reference compounds against major gram-negative pathogenic...
7.
Leitner F, Chisholm D, Tsai Y, Wright G, DeRegis R, PRICE K
Antimicrob Agents Chemother
. 1975 Mar;
7(3):306-10.
PMID: 1137382
The bioavailability and therapeutic properties of BL-S 640 in rodents were compared with those of cephalothin, cephaloridine, and cefazolin after parenteral administration, and cephalexin after oral administration. When given intramuscularly...
8.
PRICE K, Chisholm D, MISIEK M, Leitner F, Tsai Y
J Antibiot (Tokyo)
. 1972 Dec;
25(12):709-31.
PMID: 4486599
No abstract available.
9.
PRICE K, Chisholm D, Godfrey J, MISIEK M, GOUREVITCH A
Appl Microbiol
. 1970 Jan;
19(1):14-26.
PMID: 5415210
The relative antimicrobial activity of a large series of semisynthetic coumermycins has been determined. Most of the derivatives, which were 3-substituted-4-hydroxy-8-methyl-7-[3-O-(5-methyl-2-pyrrolylcarbonyl) noviosyloxy] coumarins, had an in vitro antibacterial spectrum similar...
10.
PRICE K, Leitner F, MISIEK M, Chisholm D, PURSIANO T
Antimicrob Agents Chemother (Bethesda)
. 1970 Jan;
10:17-29.
PMID: 5000254
No abstract available.